🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A new community is forming at the place with the blue sky! Join the movement and get your #SNO2024 updates there.

nytimes.com/2024/11/21/tec… via @NYTimes

We are thrilled to announce that GCAR has executed an agreement with AstraZeneca for the evaluation of AstraZeneca’s compound, AZD1390, in GBM AGILE, the world’s first global adaptive platform trial for patients with #glioblastoma. The AZD1390 arm will be evaluated for the

Such an interesting story on systemic T cell response inhibition presented by Alexandra Hoyt-Miggelbrik from the Katayoun Ayasoufi Lab Duke Neurosurgery #SNO2024

“Team science is what’s going to move us forward, it’s what drives discovery,” said Dr. Mitchel S. Berger of UCSF Neurosurgery and ABTA board member, during his acceptance speech of the SNO Lifetime Achievement Award. Thank you, Mitch, for your leadership! 🏆

Delighted to share our comprehensive review on leptomeningeal disease now online NatureRevClinOncol Items covered: 1. Distinct pathogenesis of LMD and how it varies from parenchymal brain metastases 2. How cancer cells metabolically in the CSF and evade immune cells 3. Latest

🚨🥁🥁🥁 Hot off the press! NatureRevClinOncol 🚨 Leptomeningeal Metastatic Disease: New Frontiers and Future Directions - Discover groundbreaking insights into LMD in our latest review. ✅From novel diagnostics to cutting-edge therapies like intrathecal and immunotherapies, we

Anonymous donor gives $50 million to Duke for a proton beam therapy center #protonbeamtherapy neurosurgery.duke.edu/news/anonymous…

Honored & humbled

Very proud of you ZZ Zhao Zhang

Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding: Cancer Cell cell.com/cancer-cell/fu…

Check out our latest article in Neuro-Oncology, wherein we outline challenges, lessons learned, and even resources (including protocols) for anyone interested in liquid biopsy studies. "Hitchhiker’s Guide Toward CSF Biomarkers for Neuro-Oncology" Jeffrey Zuccato Mustafa Khasraw (find me in BlueSky)

It's a huge honor to be a part of this truly remarkable set of speakers at the Stand Up for Science rally tomorrow in DC in front of the Lincoln Memorial! (My first speech at this kind of an event!)

A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion biorxiv.org/content/10.110…

Governments to academia:

JCI - IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models jci.org/articles/view/… Kirit Singh

Honored to be recognized as the Pennsylvania Medical Society Top 40 under 40. Grateful for my patients, colleagues and mentors who inspire me daily to keep pushing for better answers. Sean S. Mahase, MD Penn State Neurosurgery PennStateGME #Cancer bit.ly/43tLTZw

Congrats Stephen Bagley DrORourke and colleagues Penn Medicine - Abramson Cancer Center on their manuscript in Nature Medicine showing safety and early efficacy of bivalent CAR T cells in 18 patients with recurrent #glioblastoma! nature.com/articles/s4159…

Primary results of RELATIVITY-098 showing that adjuvant nivo+rela does not improve RFS over nivo alone, HR 1.01, biomarker data pointing to value of presence of tumor as a potential requirement for LAG3 blockade to improve efficacy. Neoadjuvant Nivo/rela had >60% MPR